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Background: Dust exposure is a well-known occupational hazard for terrestrial workers and astronauts alike and
will continue to be a concern as humankind pursues exploration and habitation of objects beyond Earth.
Humankind’s limited exploration experience with the Apollo Program indicates that exposure to dust will be
unavoidable. Therefore, NASA must assess potential toxicity and recommend appropriate mitigation measures to
ensure that explorers are adequately protected. Visual acuity is critical during exploration activities and operations
aboard spacecraft. Therefore, the present research was performed to ascertain the ocular toxicity of authentic lunar
dust.
Methods: Small (mean particle diameter = 2.9 ± 1.0 μm), reactive lunar dust particles were produced by grinding
bulk dust under ultrapure nitrogen conditions. Chemical reactivity and cytotoxicity testing were performed using
the commercially available EpiOcularTM assay. Subsequent in vivo Draize testing utilized a larger size fraction of
unground lunar dust that is more relevant to ocular exposures (particles <120 μm; median particle
diameter = 50.9 ± 19.8 μm).
Results: In vitro testing indicated minimal irritancy potential based on the time required to reduce cell viability by
50% (ET50). Follow-up testing using the Draize standard protocol confirmed that the lunar dust was minimally
irritating. Minor irritation of the upper eyelids was noted at the 1-hour observation point, but these effects resolved
within 24 hours. In addition, no corneal scratching was observed using fluorescein stain.
Conclusions: Low-titanium mare lunar dust is minimally irritating to the eyes and is considered a nuisance dust for
ocular exposure. No special precautions are recommended to protect against ocular exposures, but fully shielded
goggles may be used if dust becomes a nuisance.Background
According to the Centers for Disease Control and Pre-
vention, about 2000 US workers have medically relevant
job-related eye injuries each day [1]. The majority of
these injuries result from small particles, including dust,
impacting or abrading the eye. The lunar regolith, which
includes dust, is a product of billions of years of meteor-
ite impacts, micrometeorite impacts, cosmic dust, solar
wind hydrogen implantation, and ionizing radiation. It is
several meters thick in all areas where it has been mea-
sured [2]. Current experience with human exposure to
lunar dust is limited to the Apollo program. Astronauts
who explored the lunar surface acquired large amounts
of dust on their spacesuits (Figure 1), which returned
with them in their spacecraft. When the vehicle left the* Correspondence: john.t.james@nasa.gov
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reproduction in any medium, provided the orlunar surface and returned to microgravity operations
on the return trip to Earth, the lunar dust became air-
borne and was reported to be irritating to the eyes of
Apollo astronauts [3]. The crew’s response at the time
was to simply don their helmets until the dust was
cleared from the atmosphere of the vehicle by filters in
the environmental control and life support system. No
reports of injury were found in the available NASA
records.
NASA anticipates that long stays on the surface of the
Moon or other celestial bodies will provide many oppor-
tunities to bring surface dust back into the living areas,
both unintentionally and for scientific study. Once inside
the habitat, that dust will slowly settle depending on par-
ticle size and gravitational forces. Furthermore, dust is
expected to be removed by air filtration, presumably by
high-efficiency particulate air (HEPA) filters or their
equivalent. As a result, exposures of no more than a few
hours to dust that could be an ocular irritant areLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Apollo 12 spacesuit. An image depicting the lunar
surface and dust collecting on the spacesuit of an Apollo astronaut. Figure 2 Apollo 14 lunar dust image. A scanning electron
micrograph image of authentic lunar dust with iron metal inclusions.
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5 days per week for 26 weeks or more as astronauts re-
turn from their work on the surface of a celestial body.
To determine the potential hazard caused by these expo-
sures, NASA decided to evaluate the potential for lunar




The parent sample consisted of soil from the Apollo 14
mission (sample no. 14003,96). Figure 2 shows a scan-
ning electron micrograph of the dust containing iron
metal inclusions. The material was separated by pneu-
matic means within a glovebox containing ultrapure
nitrogen (0.5 ppm H2O, 20.6 ppm O2), using the tech-
nique described in Cooper et al. [4]. To determine
the mechanical irritancy or abrasiveness of the lunar
dust, the fraction of material separated by pneumatic
means described above with a mean particle size of
50.9± 19.8 μm was used for in vivo testing.
To prepare the sample for in vitro testing, an in-house
jet-mill grinding method was used to grind coarse lunar
soil grains to produce smaller particles and restore sur-
face reactivity which may have been lost after years of
storage. This method allowed us to test for the max-
imum chemical irritancy potential of the lunar dust,
since grinding is expected to lead to a higher degree of
surface reactivity due to the generation of silicon- or
oxygen-based radicals (“dangling bonds”), which can
react with water to produce hydroxyl radicals. It is also
possible that grinding of lunar dust exposes reducediron, which can react with oxygen and water to produce
ROS, including hydrogen peroxide or superoxide [5].
The material was ground to a median particle diameter
of 2.9 ± 1.0 μm. Previous work has shown that surface
reactivity generated by grinding is greatly reduced or
“passivated” over the course of a few hours by contact
with humidity and atmospheric oxygen [5]. Conse-
quently, all handling of the lunar soil (both separation
and grinding) was performed in an ultrapure nitrogen
environment to minimize its exposure to reactive atmos-
pheric species until the tissues were dosed.In vitro testing
In vitro ocular testing was performed by Stillmeadow,
Inc. using the commercially available EpiOcularTM
model. This model utilizes human-derived epidermal
keratinocytes that have been cultured to form a strati-
fied corneal epithelium [6]. Cell viability following ex-
posure to lunar dust was determined by conversion
of 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bro-
mide (MTT) and was expressed as a percentage relative
to untreated (negative control) tissues.
Tissue Exposure - MatTek assay medium (MTT-100-
ASY) was pre-warmed to 37°C in a 5% CO2 incubator,
and 0.9 mL was aliquoted into each well of a sterile 6-
well plate. Each insert, containing room-temperature
EpiOcularTM tissue, was aseptically placed in one of six
wells containing pre-warmed assay media and incubated
for one hour at 37°C, under 5% CO2. Following incuba-
tion, the media was aspirated and then replaced with an
identical volume of pre-warmed media. Approximately
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EpiOcular™ tissues for each exposure time of 3, 30 and
60 minutes, as recommended by the manufacturer
(MatTek). Additional tissues were dosed in duplicate
each with exposure times of 3, 30 and 60 minutes to
serve as dust controls using the following: sodium dode-
cyl sulfate (SDS) (Mfg: Fisher Bioreagents; Lot: 094466;
Exp: Jan 2020), sodium hydroxide (NaOH) (Mfg: MP
Biomedicals, LLC; Lot: 7367 J; Exp: Jan 2020) and
hydrated amorphous silica (Mfg: Bel-Art Products; CAS
112926-00-8/7631-86-9; Exp: Jan 2020). Two tissues
were exposed to 100 μL of deionized (DI) water for 60
minutes to serve as a negative control. The positive con-
trol, 0.3% Triton X-100, was used to dose two tissue repli-
cates for each exposure time of 3, 30 and 60 minutes.
After exposure of the tissues was complete, tissues
were gently rinsed with calcium- and magnesium-free
phosphate buffered saline (PBS) until all test material
was removed from each tissue insert, and any liquid
remaining on the tissues was aspirated off. Each insert
was then submerged in pre-warmed assay media and
incubated for 10 minutes at 37°C, under 5% CO2.
Supplied MTT concentrate (MTT-100-CON) was
thawed, diluted with the provided diluent (MTT-100-
DIL), and mixed well. Three hundred microliters of
MTT solution were added to each well of a sterile 24
well plate, and both it and a second empty 24 well plate,
to be used in the extraction process, were labelled ap-
propriately for each insert.
Following the 10 minute incubation, tissues were
placed in a sterile 24-well plate containing 300 μl MTT
solution per well, and returned to a 37°C, 5% CO2 incu-
bator for 3 hours. Following the 3 hour MTT incubation,
the tissues were gently rinsed with PBS to remove any
remaining MTT solution and blotted with a Kimwipe.
Tissue inserts were then added to the pre-labelled
24-well plate, immersed in 2 mL extractant solution
(MTT-100-EXT) per well, and sealed inside a zip-top plas-
tic bag to prevent evaporation. The tissues were allowed
to extract overnight at room temperature in the dark.
Direct MTT Reduction - A decrease in MTT reduction
capacity is used as the indicator of potential irritancy.
Therefore, it is important to determine the MTT reduc-
tion potential of the test substance itself. To accomplish
this, 100 mg of SDS, amorphous silica, NaOH and lunar
dust were each added to Eppendorf tubes containing
1 mL MTT solution. One hundred μL of DI water were
added to 1 mL MTT solution as a negative control.
Tubes were placed in the dark at room temperature for
approximately 60 minutes, and then assessed for color
change to purple, indicative of auto-reduction. Any dir-
ect MTT reduction was measured photometrically and
subtracted from the values obtained for the treated
tissues.Determination of ET-50 - After transfer of tissue
inserts to MTT plates and extraction were completed,
any extraction solution remaining in the inserts was dec-
anted back into the well and mixed thoroughly. Inserts
were then discarded, and 200 μL from each well of each
replicate were added to a 96 well plate in triplicate.
Reduced MTT was then quantified photometrically. The
optical density (OD) was measured at 570 nm using a
dual wave length MRX Revelation spectrophotometer.
The mean of the ODs for the two replicates for each
substance and time point were used to calculate the ET-
50 of all tissues using the manufacturer-provided spread-
sheet. Results were expressed as percent viability in the
lunar dust treated tissues relative to the negative control.
Extrapolation of ET-50 to irritation potential - A pro-
prietary spreadsheet-based model was used to correlate
the ET-50 value with the appropriate Draize irritation
score. This model was developed by the manufacturer
and based on their testing [7].
In vivo testing
In vivo ocular testing was performed by Stillmeadow,
Inc. according to U.S. Environmental Protection Agency
guidelines (OPPTS 870.2400) [8]. All procedures were in
compliance with Animal Welfare Act Regulations and
were approved by the NASA and Stillmeadow, Inc. Insti-
tutional Animal Care and Use Committees (IACUC).
Test Substance Administration - Three healthy albino
rabbits were released from quarantine five days after re-
ceipt. On Day 0, both eyes of each animal were carefully
examined prior to treatment using a fluorescein sodium
ophthalmic solution and cobalt-filtered light. Tetracaine
HCl Ophthalmic Solution (0.5%, Bausch & Lomb, Lot
133541, Exp Sep 2012) was applied immediately prior to
the fluorescein staining, with photographs of each eye
taken both prior to and following fluorescein staining.
Only those animals without extant eye defects or irrita-
tion were selected for testing. Each rabbit received
0.1 mg/kg Buprenorphine (Hospira, Lot 77531LL, Exp
Sep 2012) parenterally as an analgesic at least 45 min-
utes prior to dosing.
As recommended by OECD guideline 405, Acute Eye
Irritation/Corrosion, a dose equivalent to 0.1 mL vol-
ume, or 70 ± 2 mg of lunar dust, was placed into the
conjunctival sac of the right eye of each animal by gently
pulling the lower lid away from the eyeball to form a
cup into which the test substance was poured [9]. The
lids were gently held together for several seconds to
minimize loss of material through the blinking reflex.
The untreated left eyes served as comparative controls.
Observations – Gross observation of the treated eyes
of all animals were examined without magnification
under white room lighting provided by daylight-type
fluorescent ceiling fixtures, and (if needed) an additional
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using a handheld flashlight. All treated eyes were washed
with room temperature DI water for one minute imme-
diately after recording the 1-hour scores. If the test
substance was still visible in the rabbit eye after the 1-
minute wash, washing was continued for a maximum
of 1 additional minute (2 minutes total). Photographs
of each eye were taken at the 1-hour observation to
document the presence or absence of residual test sub-
stance after washing and at each observation period
through study termination.
The grades of ocular reaction were recorded at 1, 24,
48 and 72 hours after treatment. The corneas of all trea-
ted eyes were examined immediately after the 1- and 24-
hour observations with a fluorescein sodium ophthalmic
solution. A Finoff ocular transilluminator with cobalt
blue filter (Welch Allyn, Skaneateles Falls, NY) was uti-
lized to enhance visualization of fluorescein staining. Slit
lamp exams of any fluorescein-stained abrasions were
planned, but no abrasions were noted.
Irritation Scoring Method - Individual irritation scores
for each animal at each scheduled observation were
determined using the standard Draize scale of ocular ir-
ritancy (Appendix A). An average irritation score for
each scheduled observation was then determined, with a
maximum average irritation score derived from the ob-
servation yielding the highest average irritation score.
The maximum average irritation score was used to rate
the test substance according to the definitions presented
in Appendix B.Results and Discussion
Chemical Irritancy of Lunar Dust
OECD guideline 405 recommends that sequential test-
ing, including the use of validated in vitro tests of corro-
sion/irritation, should be conducted prior to in vivo
testing [9]. Therefore, the EpiOcularTM eye irritation
assay [6], was used to determine the relative chemical ir-
ritation produced by lunar dust prior to in vivo testing.
This human-derived in vitro model has been used
worldwide by chemical, pharmaceutical and consumerTable 1 Test results from EpiOcular in vitro testing
Lunar Dust Neg. Control Pos. Con
3 min 1.117 N/A 0.931
30 min 1.023 N/A 0.548
60 min 1.013 1.077 0.187
ET-50 >60 min N/A 30.6 m
Irritancy Minimal N/A Mild
Average OD readings at 570 nm are presented for samples exposed to each test ar
reading according to the manufacturer’s spreadsheet. Chemical irritancy classificatioproduct companies in testing approaches to reduce or
replace animal testing [10,11]. Results reported by Still-
meadow, Inc. are shown in Table 1. The ET-50 for lunar
dust was greater than 60 minutes, and the dust was
therefore classified as mildly irritating. In contrast, the
ET-50 for known chemical irritants, such as NaOH and
SDS, was less than 3 minutes.
Although in vitro ocular toxicity testing provides use-
ful information, it does have some limitations. The
EpiOcularTM assay evaluates only a single endpoint (cell
viability) in corneal epithelial cells. Additional endpoints,
such as hyperemia, swelling and mechanical injury,
effects on other ocular structures, such as the conjunc-
tiva, and physiological processes, such as blink response
and tearing, can be assessed only by using intact eyes.Mechanical Irritancy of Lunar Dust
An acute eye irritation study was performed in New
Zealand White albino rabbits to determine the mechan-
ical irritancy of lunar dust in an intact eye and to con-
firm the results of the in vitro testing. The maximum
average irritation score, using the Draize grading scale
[12], was 4.0 at the 1-hour observation point for all three
animals tested (Table 2). This score was due to slight
redness and swelling of the conjunctiva seen only at the
1-hour observation time. No corneal scratching was
observed by fluorescein staining. No adverse signs or
symptoms were noted in the cornea, iris, or conjunctiva
at any of the subsequent observation times (24, 48, and
72 hours). The lunar dust was rated as minimally irritat-
ing based on the maximum average irritation score,
which is equivalent to “Not Classified (NC) for eye irri-
tation” under the Globally Harmonized Classification
system (UN-GHS) [13]. These results are consistent
with the in vitro results and provide additional sup-
port that the EpiOcular assay system adequately pre-
dicts irritancy potential despite its limitations [14].
However, it is noted that as lunar grains become
smaller, they become more rounded in shape and may
lack abrasivity. This could explain the observed lack




in <3 min <3 min >60 min
Severe Severe Minimal
ticle for 3, 30, or 60 minutes. The ET-50 was estimated from the average OD
n was then assigned according to the corresponding ET-50.
Table 2 Maximum average irritation scores from in vivo
testing of lunar dust
Time After
Treatment
Rabbit Number Average Score
0226-M 0230-M 0275-F
Hour 1 4 4 4 4.0
Hour 24 0 0 0 0.0
Hour 48 0 0 0 0.0
Hour 72 0 0 0 0.0
Maximum Average Irritation Score: 4.0 Minimally irritating
Average irritation scores are presented for each of the three animals at each
observation time. Minor conjunctival redness and swelling were noted in all
animals 1 hour post-exposure. According to the grading scale in Appendix A,
this corresponds to an irritation score of 4. All redness and swelling resolved
within 24 hours.
M – Male; F – Female.
Table 3 The total score for the eye is the sum of all
scores obtained for the cornea, iris, and conjunctivae,
with the possible maximum total score for the eye being
equal to 110
I. Cornea (Maximum score = 80; A x B x 5)
A. Opacity–degree (area most dense taken for reading)
No opacity 0
Slight dulling of normal luster +
Scattered or diffuse areas of opacity (other than slight
dulling of normal luster), details of iris clearly visible
1
Easily discernible translucent area, details of iris slightly
obscured
2
Nacreous area, no details of iris visible, size of pupil barely
discernible
3
Opaque cornea, iris not discernible through the opacity 4
B. Area of cornea involved
One quarter (or less), but not zero 1
Greater than one quarter, but less than half 2
Greater than half, but less than three quarters 3
Greater than three quarters, up to whole area 4
C. Fluorescein staining–appearance of yellow-green
staining of cornea
Cornea not examined with fluorescein -
No fluorescein staining 0
Positive fluorescein staining P
Area of cornea involved
One quarter (or less), but not zero A
Greater than one quarter, but less than half B
Greater than half, but less than three quarters C
Greater than three quarters, up to whole area D
D. Stippling–appearance of pinpoint roughening
No stippling 0
Presence of stippling S
Area of cornea involved
One quarter (or less), but not zero A
Greater than one quarter, but less than half B
Greater than half, but less than three quarters C
Greater than three quarters, up to whole area D
II. Iris (Maximum score = 10; A x 5)
A. Grades
Normal 0
Markedly deepened rugae, congestion, swelling, moderate
circumcorneal hyperemia or injection (any of these or
combination thereof), iris still reacting to light
(sluggish reaction is positive)
1
No reaction to light, hemorrhage, gross destruction
(any or all of these)
2
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restrial dusts, such as volcanic ash, which is often used
as a simulant for lunar dust. After the eruption of
Mount St. Helens in 1980, ophthalmologists observed
that ash particles were well-tolerated by those exposed,
producing acute irritation but no long-term ocular
effects [15]. Similarly, a recent 10-year survey of ocular
effects in school-aged children exposed to volcanic ash
reported that those in high-exposure areas did have a
higher incidence of ocular symptoms, but these were
limited to minor, acute effects (redness, itching, foreign-
body sensation, and discharge) that were readily treat-
able with eye drops [16]. Desert sands are similarly
acutely irritating to the eye [17].
There are limitations to our study. Only one source of
lunar dust, generally representative of low-Titanium
mare lunar dust, was tested. Dust from the highlands
area of the lunar surface has a substantially different
mineral content, and therefore, these results may not be
representative of that dust nor of dust from exotic loca-
tions such as the permanently dark areas in the basins of
craters near the poles.
Conclusions
These results suggest that lunar dust like that returned
aboard Apollo 14 will not cause significant eye irritation
once nominal operations commence on the lunar sur-
face. No special precautions are recommended to pro-
tect against ocular exposures; however, it is noted that
contact lens wearers may be more susceptible to irrita-
tion from dust that may become trapped under the lens.
Fully shielded goggles may be used if dust becomes a
nuisance. If irritating grains do enter the eye, an eyewash
station is recommended to remove the offending dust. It
is important to note that this study focused exclusively
on the ocular toxicity of lunar dust. Other potential
routes of exposure, including inhalation and dermal irri-
tation, are being examined.Appendices
Appendix A-Grading Scale for the Acute Eye Irritation
Study in Rabbits12
Table 3 The total score for the eye is the sum of all
scores obtained for the cornea, iris, and conjunctivae,
with the possible maximum total score for the eye being
equal to 110 (Continued)
III. Conjunctivae (Maximum score = 20; (A+B+C) x 2)
A. Redness (refers to palpebral and bulbar conjunctivae
excluding cornea and iris)
Blood vessels normal 0
Some blood vessels definitely hyperemic (injected) 1
Diffuse, crimson color, individual vessels not easily discernible 2
Diffuse beefy red 3
B. Chemosis: lids and/or nictitating membrane
No swelling 0
Any swelling above normal (includes nictitating membrane) 1
Obvious swelling with partial eversion of lids 2
Swelling with lids about half closed 3
Swelling with lids more than half closed 4
C. Discharge
No discharge 0
Any amount different from normal (does not include small
amounts observed in inner canthus of normal animals)
1
Discharge with moistening of the lids and hairs just adjacent
to lids
2
Discharge with moistening of the lids and hairs, and
considerable area around the eye
3
D. Necrosis or ulceration of the palpebral and bulbar
conjunctivae or nictitating membrane
No necrosis or ulceration 0
Presence of necrosis or ulceration N
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Irritation
Non-irritating (0.0–0.5) - To maintain this rating, all
scores at the 24-hour reading must be zero; otherwise,
increase rating one level.
Practically non-irritating (>0.5–2.5) - To maintain this
rating, all scores at the 24-hour reading must be zero;
otherwise, increase rating one level.
Minimally irritating (>2.5–15.0) - To maintain this rat-
ing, all scores at the 72-hour reading must be zero;
otherwise, increase rating one level.
Mildly irritating (>15.0–25.0) - To maintain this rating,
all scores at the 7-day reading must be zero; otherwise,
increase rating one level.
Moderately irritating (>25.0–50.0) - To maintain this
rating, scores at the irritating 7-day reading must be less
than or equal to 10 for 60% or more of the animals; also,the 7-day mean score must be less than or equal to 20.
If the 7-day mean score is less than or equal to 20, but
less than 60% of the animals show scores less than or
equal to 10, then no animal with a score greater than 10
can exceed a score of 30 if rating is to be maintained;
otherwise, increase rating one level.
Severely irritating (>50.0–80.0) - To maintain this rat-
ing, scores at the irritating 7-day reading must be less
than or equal to 30 for 60% or more of the animals; also,
the 7-day mean score must be less than or equal to 40.
If the 7-day mean score is less than or equal to 40, but
less than 60% of the animals show scores less than or
equal to 30, then no animal with a score greater than 30
can exceed a score of 60 if rating is to be maintained;
otherwise, increase rating one level.
Extremely irritating (>80.0–110.0)
NOTE: The rating of the test substance is not to be
increased more than one level above its maximum
average score.
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